Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Truly Technologies
AddedFeb 19, 2024
UpdatedJun 18, 2026
Truly Technologies

Truly Technologies

Angel

Truly Technologies: Innovating biospecimen processing for diagnostics and life science research.

HQ
Seattle, WA, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Truly Technologies was founded with the mission to innovate biospecimen processing for diagnostics, therapeutics, and life science research. The company focuses on developing advanced bioprocessing solutions that concentrate biomolecules at high yield and purity using osmotic pressure across a semipermeable membrane. Their technology addresses a wide range of bioprocessing challenges, providing a simple and efficient method for both concentration and purification of biomolecules.

Notable figures affiliated with Truly Technologies include experts in biotechnology and life sciences, though specific names are not provided. The company has achieved significant milestones in developing its proprietary technology, which has the potential to revolutionize diagnostic and therapeutic processes. By enhancing the efficiency and effectiveness of biomolecule processing, Truly Technologies is poised to make a substantial impact on the fields of diagnostics and life science research.

Truly Technologies - Similar Companies

Truwl logo

Truwl

SeeTrue Technology logo

SeeTrue Technology

Zymeron logo

Zymeron

zymeron.com

tru logo

tru

tru-inc.com

AthemBio logo

AthemBio

athembio.com

Truly logo

Truly

truly.co

Proteios Technology logo

Proteios Technology

proteios.com

TriMetis Life Sciences logo

TriMetis Life Sciences

Qatch Technologies logo

Qatch Technologies

qatchtech.com

ActivSignal logo

ActivSignal

activsignal.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Transcera logo

Transcera

Glyphic Biotechnologies logo

Glyphic Biotechnologies

glyphic.bio

Inso Biosciences logo

Inso Biosciences

inso.bio

SeqLL logo

SeqLL

seqll.com

Truly Technologies - Quick Facts

Who are Truly Technologies' competitors?

Companies similar to Truly Technologies include Truwl, SeeTrue Technology, Zymeron and tru.

When was Truly Technologies founded?

Truly Technologies was founded in 2021.

Where is Truly Technologies' headquarters located?

Truly Technologies' headquarters is located in Seattle, WA, US.

When was Truly Technologies' last funding round?

Truly Technologies' most recent funding round was for $272.6k (USD) in May 2023.

How much has Truly Technologies raised to-date?

As of May 1, 2023, Truly Technologies has raised a total of $303.4k (USD).

How many employees does Truly Technologies have?

Truly Technologies has 2 employees as of Feb 4, 2024.

Truly Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Bioprocessing
  • Devices
Tags
  • Biotech
  • Medical Devices
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software